Posts in tag

medicine shortages


PBS clarifies subsidy arrangements for HRT patches subject to SSSI  Pharmacists can dispense certain overseas-registered hormone replacement therapy (HRT) patches under the Pharmaceutical Benefits Scheme (PBS) without needing a new …

Recommendations for the government to support the domestic production of HRT medicines are currently not feasible, Department says  Domestic manufacture of hormone replacement therapy (HRT) products is likely to be …

“Patients are suffering unnecessarily”, because the medications that typically control their symptoms are either unavailable or prohibitively expensive, Palliative Care Australia says  Palliative Care Australia is calling on the government …

Pharmacists are “moving heaven and earth” to find stock of ADHD medications that are in short supply, with some children missing out as the school year begins Shortages of Concerta …

Shortages of hormone replacement therapy (HRT) patches are set to continue in 2025, PBS warns  Pharmacists are being reminded that some, but not all, of the HRT products covered by the …

Diabetes medication to remain in short supply throughout 2025, manufacturer warns  Efforts to boost the production of Ozempic (semaglutide) are not expected to alleviate shortages of the medication in the …

Medicines shortages are taking a toll on the majority of pharmacists, according to a new survey, with almost a third reporting patient frustration over GLP-1s An “overwhelming majority” of pharmacists …

Ongoing shortages of tenofovir with emtricitabine tablets prompt temporary PBS listing of alternative brand  The Department of Health and Aged Care will temporarily list US approved medication, Emtricitabine and Tenofovir …

Prevalence of add-on therapy in people with type 2 diabetes is “low” and should be increased to save lives, PBS records analysis finds More Australians with type 2 diabetes need …

Pharmacies can expect to have improved access to stocks of Bristol-Myers Squibb’s Orencia (abatacept) 125mg/mL ClickJect autoinjector for subcutaneous injection and prefilled syringe products  Following months of supply issues, the …

Politicians are being urged to reconsider the decision to ban the compounding of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) until supply issues ease  Patients are calling for the government’s decision …

Patients face increased out-of-pocket costs due to regulations preventing pharmacists from making clinical decisions to substitute prescribed medications when supply shortages hit  Regulatory changes are needed to give pharmacists greater …